Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Home Healthcare Now|November 4, 2024
Reducing Violence Risk: Home Healthcare Nurses and Early Identification of Informal Caregiver BurdenPaula Lambert
Assessment|March 26, 2026
Assessing Burnout in Daily Life: Empirically Derived Short Versions of the Burnout Assessment Tool (BAT) for Capturing Momentary and Daily BurnoutDorota Reis, Paul Stasch, Lisa Peuckmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusionScott Wadler, Della Makower, Caroline Clairmont, et al.
The Open Dentistry Journal|April 15, 2015
Root Resorption a 6-Year Follow-up Case ReportCaroline Dias, Luciane Closs, Fernando Barletta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumorsJohn Murren, Manuel Modiano, Caroline Clairmont, et al.
The Journal of Contemporary Dental Practice|August 29, 2018
Mesiolingual Canal Prevalence in Maxillary First Molars assessed through Different MethodsAlissa L Zurawski, Paula Lambert, Caroline Solda, et al.
Brazilian Dental Journal|December 6, 2018
Effect of At-Home Bleaching on Oxygen Saturation Levels in the Dental Pulp of Maxillary Central IncisorsCaroline Solda, Fernando Branco Barletta, José Roberto Vanni, et al.
Restorative Dentistry & Endodontics|December 9, 2020
Reference values for pulp oxygen saturation as a diagnostic tool in endodontics: a systematic review and meta-analysisPaula Lambert, Sergio Augusto Quevedo Miguens, Caroline Solda, et al.
Leukemia Research|August 19, 2003
Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemiaFrancis J Giles, Paula M Fracasso, Hagop M Kantarjian, et al.
Pageof 1